PRPF19 and cancer: Since that MYL9 contributes to the stiffer matrix and leads to Src activation, and Src is a well-known upstream driver of YAP in cancer metastasis [32], we supposed that the PRPF19/MYL9 may regulate the Src/YAP pathway in CRC.